Clinical Trial Update: Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) [Phase 3]

View source ↗

Summary

A Phase 3 study (DURATION-3) evaluated adding exenatide weekly and once-daily insulin glargine to metformin (± sulfonylurea) in adults with Type 2 diabetes; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Byetta (exenatide) (exenatide)
• Lantus (insulin glargine) (insulin glargine)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04